All filters
Abstracts
Community perspectives on self- testing for HIV and HCV in the WHO European region
S. North Reviews in Antiviral Therapy & Infectious Diseases 3, 2022
Presented at:
European Meeting on HIV & Hepatitis 2022
Abstracts
Viral load suppression after three-year Ibalizumab treatment in a multidrug-resistant HIV-1- infected woman: Clinical experience.
I. Santos Reviews in Antiviral Therapy & Infectious Diseases 3, 2022
Presented at:
European Meeting on HIV & Hepatitis 2022
Abstracts
CASE - HIV+ End-Stage Renal Disease Patient with Immunosuppressive Drug-Drug Interactions Received Successful Transplantation after Ibalizumab Suppressed Switch
S. Sharma Reviews in Antiviral Therapy & Infectious Diseases 3, 2022
Presented at:
European Meeting on HIV & Hepatitis 2022
Abstracts
Clinical course of AIDS with COVID-19 coinfection with prolonged SARS CoV-2 replication despite remdesivir/molnupiravir treatment.
B. Aksak-Wąs Reviews in Antiviral Therapy & Infectious Diseases 3, 2022
Presented at:
European Meeting on HIV & Hepatitis 2022
Abstracts
A Case of IRIS Syphilis Due to Prozone Effect
Y. Rahman Reviews in Antiviral Therapy & Infectious Diseases 3, 2022
Presented at:
European Meeting on HIV & Hepatitis 2022
Meeting
International Workshop on HBV Cure 2021
9 Nov 2021 - 10 Nov 2021
Virtual Meeting
Meeting
Central and Eastern European Meeting on Viral Hepatitis and HIV 2021
14 Oct 2021 - 15 Oct 2021
Virtual Meeting
Slidesets
Update on the Efficacy and Safety of Bulevirtide for Treatment of Chronic HDV - D. Manuilov, MD
Presented at:
International Workshop on HBV Cure 2021
Slidesets
Active Site Polymerase Inhibitor Nucleotides (APSINs) - D. Mayers, MD
Presented at:
International Workshop on HBV Cure 2021
Slidesets
STOPS Agents - M. McClure, MD
Presented at:
International Workshop on HBV Cure 2021
Slidesets
Antisense Oligos - L. Felton, Bsc, PhD
Presented at:
International Workshop on HBV Cure 2021
Slidesets
Core Inhibitors (Capsid Assembly Modulators) - Luisa Stamm, MD, PhD
Presented at:
International Workshop on HBV Cure 2021
Slidesets
Biological Insights Taught by Clinical Responses to Novel Hbv-Hdv Drugs - S. Urban, PhD
Presented at:
International Workshop on HBV Cure 2021
Slidesets
How to Handle Flares in HBV Trials With Novel Agents - Harry Janssen, MD, PhD
Presented at:
International Workshop on HBV Cure 2021
Slidesets
HBsAg Loss. A Predictor of Long-Term Clinical Outcomes - M. Peters, MD
Presented at:
International Workshop on HBV Cure 2021
Slidesets
A Novel Approach At Targeting the PD-1PD-l1 Pathway - PD-l1 Lna - A
Presented at:
International Workshop on HBV Cure 2021
Slidesets
HBV Immunotherapeutic Vaccines (Lessons from HCV) - E. Barnes, PhD, FRCP, F. Med. Sci
Presented at:
International Workshop on HBV Cure 2021
Slidesets
VBI-2601 Immunotherapeutic HBV Vaccine Candidate Overview - F. Diaz-Mitoma, MD, PhD
Presented at:
International Workshop on HBV Cure 2021
Slidesets
Immunotherapeutics in the Treatment of Chronic Hepatatis B - S. Browne, MD
Presented at:
International Workshop on HBV Cure 2021
Slidesets
Anti-HBs Antibody - C. Hwang, MD, PhD
Presented at:
International Workshop on HBV Cure 2021
Slidesets
TLR-8 Agonist - S. Fletcher, PhD
Presented at:
International Workshop on HBV Cure 2021
Slidesets
What Can We Learn by Deploying Immunological Analysis in Phase II Clinical Trials - A. Gehring, PhD
Presented at:
International Workshop on HBV Cure 2021
Slidesets
Patient Selection for Clinical Trials Based on Drug Class - F. Zoulim, MD, PhD
Presented at:
International Workshop on HBV Cure 2021